Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 24 (RPL36AP24)

Target: RPL36AP24
Molecular classification: Other (specifically, "Pseudogene")

Overview

Ribosomal protein L36a pseudogene 24 (RPL36AP24) is a processed pseudogene in humans that is homologous to the coding gene RPL36A, which encodes a component of the 60S ribosomal subunit. RPL36AP24 itself does not produce a functional protein, but, like other pseudogenes, it may have potential regulatory influences on gene expression or participate in noncoding RNA networks. Currently, no direct functional, disease-related, or drug-target roles have been established for RPL36AP24.

Other names: RPL36A_10_733Ribosomal protein L36a pseudogene 24

Mechanism of action

None. There are no drugs targeting this pseudogene, so there are no mechanisms of action to report.

Biological functions

Other (non-coding, potential regulatory role)

Disease associations

Other

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 24 (RPL36AP24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 24 (RPL36AP24).

Explore the full profile